IRIS
POLLICINO, Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.461
NA - Nord America 5.573
AS - Asia 3.087
SA - Sud America 1.018
AF - Africa 93
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.472
RU - Federazione Russa 3.214
SG - Singapore 1.222
CN - Cina 950
BR - Brasile 909
IE - Irlanda 779
SE - Svezia 706
IT - Italia 435
HK - Hong Kong 368
DE - Germania 303
FR - Francia 203
FI - Finlandia 186
PL - Polonia 181
UA - Ucraina 179
VN - Vietnam 165
GB - Regno Unito 114
IN - India 91
MX - Messico 41
CA - Canada 40
BD - Bangladesh 39
IQ - Iraq 37
TR - Turchia 36
BE - Belgio 33
AR - Argentina 30
ZA - Sudafrica 29
ID - Indonesia 26
ES - Italia 23
JP - Giappone 22
NL - Olanda 22
PK - Pakistan 21
CZ - Repubblica Ceca 20
AT - Austria 19
CO - Colombia 18
MA - Marocco 18
UZ - Uzbekistan 18
EC - Ecuador 15
KE - Kenya 11
PY - Paraguay 11
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
JO - Giordania 8
NZ - Nuova Zelanda 8
PE - Perù 8
TN - Tunisia 8
GR - Grecia 7
LT - Lituania 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
BO - Bolivia 6
CI - Costa d'Avorio 6
CL - Cile 6
KG - Kirghizistan 6
LB - Libano 6
NP - Nepal 6
PH - Filippine 6
BG - Bulgaria 5
EG - Egitto 5
HN - Honduras 5
MY - Malesia 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
CH - Svizzera 4
IR - Iran 4
JM - Giamaica 4
OM - Oman 4
AO - Angola 3
DZ - Algeria 3
GT - Guatemala 3
IL - Israele 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MN - Mongolia 2
PT - Portogallo 2
QA - Qatar 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
RO - Romania 1
Totale 16.239
Salva come PNG Salva come JPEG
Città #
Ashburn 1.282
Moscow 975
Dublin 779
Dallas 717
Singapore 714
Chandler 543
Nyköping 408
Jacksonville 371
Hong Kong 368
Beijing 353
Messina 256
San Jose 189
Warsaw 167
The Dalles 142
Los Angeles 137
Princeton 119
Ann Arbor 117
Munich 106
Lauterbourg 102
Medford 98
Cambridge 90
Des Moines 83
São Paulo 75
Ho Chi Minh City 64
New York 64
Boardman 63
Dearborn 51
Helsinki 47
Houston 46
Buffalo 43
Jinan 41
Turku 40
Frankfurt am Main 37
Wilmington 36
Woodbridge 36
Brussels 32
Orem 32
Tianjin 32
Brasília 30
Council Bluffs 30
Hanoi 30
Belo Horizonte 29
Guangzhou 29
Pune 27
Redondo Beach 27
San Mateo 27
Santa Clara 23
Chennai 22
Rio de Janeiro 22
Falls Church 21
Nanjing 21
Tokyo 21
Phoenix 20
Shanghai 20
Shenzhen 19
Boston 18
Stockholm 18
Zhengzhou 18
Brooklyn 17
Jakarta 17
Nuremberg 17
Tashkent 17
Atlanta 16
Dong Ket 16
Johannesburg 16
Rome 16
Mexico City 15
Shenyang 15
Porto Alegre 14
Rosolini 14
Baghdad 13
Brno 13
Chicago 13
Hebei 13
Amsterdam 12
Lahore 12
Lappeenranta 12
London 12
Montreal 12
San Francisco 12
Manchester 11
Norwalk 11
Salvador 11
Seattle 11
Denver 10
Dhaka 10
Düsseldorf 10
Guarulhos 10
Haiphong 10
Mumbai 10
Poplar 10
Fortaleza 9
Haikou 9
Hangzhou 9
Nairobi 9
Catania 8
Curitiba 8
Goiânia 8
Ottawa 8
Tappahannock 8
Totale 9.831
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 376
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 264
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 260
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 248
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 223
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 217
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 213
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 207
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 207
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 206
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 200
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 197
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 196
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 190
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 187
Control of cccDNA function in hepatitis B virus infection. 186
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 184
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 182
[A glance into the past ... Southern and northern blot: really superseded?] 179
Mitochondrial DNA is a target of HBV integration 178
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 174
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 171
A 2010 update on occult hepatitis B infection. 170
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 168
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 168
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 168
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 167
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 166
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice 166
Clinical virology of hepatitis B virus infection 165
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 165
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 165
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 164
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 161
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 160
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 157
Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. 154
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 154
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 154
Disease progression and liver cancer in the ferroportin disease. 154
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 153
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 150
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 149
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 149
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 147
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 146
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. 144
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 144
Obesity and liver cancer 144
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 143
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 142
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 141
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 139
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 139
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook 138
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 138
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 138
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 136
Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection 133
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 133
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 132
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 128
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 127
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 125
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 125
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 125
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 123
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 122
Targeting Hepatitis B virus infected cells with a T-cell receptor like antibody 121
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 119
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 119
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 119
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 114
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 112
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 111
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 110
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 110
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 109
Occult HBV infection 109
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 109
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 108
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 108
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 107
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3 infected patients within the Italian network VIRONET-C 107
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 105
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 104
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance 104
Occult hepatitis B virus infection 103
HBV-integration studies in the clinic: Role in the natural history of infection 102
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 101
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 93
Pro-apoptotic effect of the hepatitis B virus X gene. 92
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 91
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. 90
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. 90
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. 89
Hepatitis B viral replication influences the expression of natural killer cell ligands 89
Hepatitis Delta Virus and Hepatocellular Carcinoma 86
p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. 86
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 86
Totale 14.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021204 0 0 0 0 0 0 0 0 0 103 51 50
2021/2022745 7 57 27 30 57 16 63 33 18 99 99 239
2022/20232.196 164 250 104 176 138 224 45 100 906 14 61 14
2023/2024719 50 111 26 61 41 103 2 228 3 23 20 51
2024/20252.658 47 19 80 227 115 121 137 519 554 150 228 461
2025/20267.951 360 649 611 546 700 1.592 1.013 1.020 1.103 357 0 0
Totale 16.465